Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomide

There are a few reports in the literature implicating them in causing fixed drug eruption, the piperazine derivatives. In this case, although eszopiclone for insomnia medicinehas a piperazine ring, no eruption appeared so far. Oxatomide and hydroxyzine not only shared a piperazine ring but also shar...

Full description

Bibliographic Details
Main Authors: Mizuki Terada, Shujiro Hayashi, Maki Okamoto, Ken Igawa
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Journal of Cutaneous Immunology and Allergy
Subjects:
Online Access:https://doi.org/10.1002/cia2.12275
_version_ 1797328978556485632
author Mizuki Terada
Shujiro Hayashi
Maki Okamoto
Ken Igawa
author_facet Mizuki Terada
Shujiro Hayashi
Maki Okamoto
Ken Igawa
author_sort Mizuki Terada
collection DOAJ
description There are a few reports in the literature implicating them in causing fixed drug eruption, the piperazine derivatives. In this case, although eszopiclone for insomnia medicinehas a piperazine ring, no eruption appeared so far. Oxatomide and hydroxyzine not only shared a piperazine ring but also shared two benzene rings via a methine group (=CH–). It was suspected that this shared structural group became an antigenic determinant and resulted in cross‐reactivity. Such a unique case has not been reported before.
first_indexed 2024-03-08T06:58:42Z
format Article
id doaj.art-4a654925b8c84aa9adea0d87842e9354
institution Directory Open Access Journal
issn 2574-4593
language English
last_indexed 2024-03-08T06:58:42Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Journal of Cutaneous Immunology and Allergy
spelling doaj.art-4a654925b8c84aa9adea0d87842e93542024-02-03T06:18:33ZengFrontiers Media S.A.Journal of Cutaneous Immunology and Allergy2574-45932023-04-0162596010.1002/cia2.12275Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomideMizuki Terada0Shujiro Hayashi1Maki Okamoto2Ken Igawa3Department of Dermatology Dokkyo Medical University Mibu JapanDepartment of Dermatology Dokkyo Medical University Mibu JapanDepartment of Dermatology Dokkyo Medical University Mibu JapanDepartment of Dermatology Dokkyo Medical University Mibu JapanThere are a few reports in the literature implicating them in causing fixed drug eruption, the piperazine derivatives. In this case, although eszopiclone for insomnia medicinehas a piperazine ring, no eruption appeared so far. Oxatomide and hydroxyzine not only shared a piperazine ring but also shared two benzene rings via a methine group (=CH–). It was suspected that this shared structural group became an antigenic determinant and resulted in cross‐reactivity. Such a unique case has not been reported before.https://doi.org/10.1002/cia2.12275adverse drug eruptionspharmacology and skin‐related toxicology
spellingShingle Mizuki Terada
Shujiro Hayashi
Maki Okamoto
Ken Igawa
Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomide
Journal of Cutaneous Immunology and Allergy
adverse drug eruptions
pharmacology and skin‐related toxicology
title Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomide
title_full Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomide
title_fullStr Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomide
title_full_unstemmed Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomide
title_short Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomide
title_sort hydroxyzine induced fixed drug eruption and cross reaction with oxatomide
topic adverse drug eruptions
pharmacology and skin‐related toxicology
url https://doi.org/10.1002/cia2.12275
work_keys_str_mv AT mizukiterada hydroxyzineinducedfixeddrugeruptionandcrossreactionwithoxatomide
AT shujirohayashi hydroxyzineinducedfixeddrugeruptionandcrossreactionwithoxatomide
AT makiokamoto hydroxyzineinducedfixeddrugeruptionandcrossreactionwithoxatomide
AT kenigawa hydroxyzineinducedfixeddrugeruptionandcrossreactionwithoxatomide